WO2023057645 - METHODS FOR THE PRODUCTION OF SORANGICINS AND THEIR ANALOGUES
National phase entry is expected:
Publication Number
WO/2023/057645
Publication Date
13.04.2023
International Application No.
PCT/EP2022/077994
International Filing Date
07.10.2022
Title **
[English]
METHODS FOR THE PRODUCTION OF SORANGICINS AND THEIR ANALOGUES
[French]
PROCÉDÉS DE PRODUCTION DE SORANGICINES ET DE LEURS ANALOGUES
Applicants **
OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG
Universitätsplatz 2
39106 Magdeburg, DE
Inventors
SCHINZER, Dieter
Neuköllnstr. 33
38108 Braunschweig, DE
CHANG, Le
Walther-Rathenau-Strasse 58 / App. 0101
39104 Magdeburg, CN
MUNT, Maxim
Leibnizstrasse 33
39104 Magdeburg, DE
SPIESS, Oliver
Brookdeich 98
21029 Hamburg, DE
STOYKOVA, Rositsa
Matthisnstr. 1
39108 Magdeburg, BG
Priority Data
21201388.2
07.10.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1401 | |
| EPO | Filing, Examination | 5740 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 11015 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
are defined in the description, providing the key building blocks according to formulae A, B, C, D, E, and F, which are described in the description, in coupling reactions and a final cyclisation to form a compound of formula (I). The compounds produced according to the present invention are useful as antibiotics.[French]
étant telles que définies dans la description, fournissant des blocs clés selon les formules A, B, C, D, E, et F, qui sont décrits dans la description, dans des réactions de couplage et une cyclisation finale pour former un composé de formule (I). Les composés produits selon la présente invention sont utiles en tant qu'antibiotiques.